This event has ended. Visit the official site or create your own event on Sched.

View analytic
Monday, June 27 • 8:30am - 9:45am
#105: Maximize the Value of Your Product by Beginning with the End in Mind

Sign up or log in to save this to your schedule and see who's attending!

Limited Capacity seats available

Component Type: Forum
Level: Intermediate
CE: CME 1.25; IACET 1.25; PDU 1.25 PMI 2166-000189; RN 1.25

Less than 1% of compounds make it to market. It is critical for biopharmaceutical developers to evaluate their probability of success. In this interactive forum, experts will share their insights to help you maximize the value of your asset.

Learning Objectives

Describe the elements of a regulatory strategy and why it is needed; Discuss the value of your product as part of your development strategy; Explain why and how to develop a target product profile; Discuss how the TPP guides the drug development process and sets expectations; Describe how to avoid typical reasons for delays and denials of a product marketing application.


Jayanthi Reddy, MBA, MS, PMP


Bill Hanlon, PhD

Carrie Furin


Jayanthi Reddy

Director and Cardiovascular Pipeline Leader, Global Project Management, Merck & Co., Inc.
Jay has over 20 years of pharmaceutical industry experience and over 14 years of project Management experience. She is currently the cardiovascular franchise leader within the Project Management group at Merck.

avatar for Carrie Furin

Carrie Furin

Pharmaceutical Project Manager, Eli Lilly and Company
Carrie is a Pharmaceutical Project Manager with Eli Lilly and Company overseeing Oncology drug development projects. She has over 10 years of drug development experience in clinical operations and project management. Carrie has led teams across multiple therapeutic areas and phases, which has provided her insight on the importance of planning, bridging the space between sound science and commercial success, and team communication. Carrie has a BA... Read More →
avatar for Bill Hanlon

Bill Hanlon

VP, Head of Global Regulatory Affairs, Covance Inc.
Dr. Hanlon is Vice President and Head of Global Regulatory Affairs at Covance. His group is responsible for all project related regulatory activities involving strategic drug development planning, medical & regulatory writing, Health Authority meetings and regulatory document submissions. Prior to joining Covance, Dr. Hanlon spent 24 years in the Pharmaceutical Industry, most of that time at Merck Research Laboratories in Rahway, NJ

Monday June 27, 2016 8:30am - 9:45am
107AB Pennsylvania Convention Center 1101 Arch Street, Philadelphia, PA 19107 USA